Zobrazeno 1 - 10
of 294
pro vyhledávání: '"Boli Zhang"'
Autor:
Yanli Liu, Tao Wang, Qilong Zhou, Guang Xin, Hai Niu, Fan Li, Yilan Wang, Shiyi Li, Yuman Dong, Kun Zhang, Lijuan Feng, Wei Fu, Boli Zhang, Wen Huang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Thromboembolism resulting from platelet dysfunction constitutes a significant contributor to the development of cardiovascular disease. Sirtuin 6 (SIRT6), an essential NAD+-dependent enzyme, has been linked to arterial thrombosis when absent in endot
Externí odkaz:
https://doaj.org/article/e11667b9023046b8b18c45a7f6b48541
Publikováno v:
Engineering, Vol 20, Iss , Pp 63-76 (2023)
Xuanfeibaidu Formula (XFBD) is a Chinese medicine used in the clinical treatment of coronavirus disease 2019 (COVID-19) patients. Although XFBD has exhibited significant therapeutic efficacy in clinical practice, its underlying pharmacological mechan
Externí odkaz:
https://doaj.org/article/e0bac52bd9884133a1426d15c4334756
Autor:
Lin Li, Yuzheng Wu, Jiabao Wang, Huimin Yan, Jia Lu, Yu Wang, Boli Zhang, Junhua Zhang, Jian Yang, Xiaoying Wang, Min Zhang, Yue Li, Lin Miao, Han Zhang
Publikováno v:
Engineering, Vol 19, Iss , Pp 139-152 (2022)
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacological mechanis
Externí odkaz:
https://doaj.org/article/3edca213f8724ed2949d2b2662fbcbbe
Autor:
Xin Zhao, Zhifei Fu, Minghe Yao, Yu Cao, Tongtong Zhu, Rui Mao, Ming Huang, Yafen Pang, Xianghui Meng, Lin Li, Boli Zhang, Yuhong Li, Han Zhang
Publikováno v:
Food Science & Nutrition, Vol 10, Iss 2, Pp 617-630 (2022)
Abstract Dietary supplements are currently being used to ameliorate metabolic alterations via maintaining gut microflora balance. Mulberry leaf is known as medicine homologous food for its glucose‐ and lipid‐modulating properties. However, the ef
Externí odkaz:
https://doaj.org/article/41d6645d3e35422aa9e471ecbe71ccaf
Autor:
Ming Lyu, Guanwei Fan, Guangxu Xiao, Taiyi Wang, Dong Xu, Jie Gao, Shaoqin Ge, Qingling Li, Yuling Ma, Han Zhang, Jigang Wang, Yuanlu Cui, Junhua Zhang, Yan Zhu, Boli Zhang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3337-3363 (2021)
COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western medicine (WM)
Externí odkaz:
https://doaj.org/article/d909b2e6af714b7eb33733072f004363
Autor:
Qiaoyu He, Yumeng Shi, Hong Xing, Qian Tang, Jing Liu, Chunxia Li, Han Zhang, Boli Zhang, Junhua Zhang, Xiaopeng Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Xuanfei Baidu granule (XFBD) is a recommended patented drug for the prevention and treatment of Corona Virus Disease 2019 (COVID-19), which is approved by the National Medical Products Administration. XFBD suppresses the over-activated immune respons
Externí odkaz:
https://doaj.org/article/956298bffa8643cf9de61ddd844095d3
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Ischemic heart diseases are responsible for more than one-third of all deaths worldwide. Radix notoginseng is widely used to treat ischemic heart disease in China and other Asian countries, and notoginsenoside R1 (NGR1) is its characteristic and larg
Externí odkaz:
https://doaj.org/article/ccbdc0f2e1f74e65b2f25b166a66f9d2
Autor:
Jingyuan Mao, Jian Zhang, Carolyn S.P. Lam, Mingjun Zhu, Chen Yao, Shutao Chen, Zhongyong Liu, Fengrong Wang, Yonggang Wang, Xiaohua Dai, Tianfu Niu, Dongqing An, Yang Miao, Tao Xu, Bo Dong, Xiaofeng Ma, Fengru Zhang, Xiaolong Wang, Ruihong Fan, Yingqiang Zhao, Tiemin Jiang, Yuhui Zhang, Xianliang Wang, Yazhu Hou, Zhiqiang Zhao, Quan Su, Junhua Zhang, Baohe Wang, Boli Zhang
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3881-3890 (2020)
Abstract Aims Qishen Yiqi dripping pills (QSYQ) may be beneficial in patients with ischaemic heart failure (IHF). We aimed to assess the efficacy and safety of QSYQ administered together with guideline‐directed medical therapy in patients with IHF.
Externí odkaz:
https://doaj.org/article/d516089931994d96a93ef26717c2c1cd
Autor:
Xinyao Jin, Bo Pang, Junhua Zhang, Qingquan Liu, Zhongqi Yang, Jihong Feng, Xuezheng Liu, Lei Zhang, Baohe Wang, Yuhong Huang, Alice Josephine Fauci, Yuling Ma, Myeong Soo Lee, Wei'an Yuan, Yanming Xie, Jianyuan Tang, Rui Gao, Liang Du, Shuo Zhang, Hanmei Qi, Yu Sun, Wenke Zheng, Fengwen Yang, Huizi Chua, Keyi Wang, Yi Ou, Ming Huang, Yan Zhu, Jiajie Yu, Jinhui Tian, Min Zhao, Jingqing Hu, Chen Yao, Youping Li, Boli Zhang
Publikováno v:
Engineering, Vol 6, Iss 10, Pp 1147-1152 (2020)
Since its outbreak in December 2019, a series of clinical trials on coronavirus disease 2019 (COVID-19) have been registered or carried out. However, the significant heterogeneity and less critical outcomes of such trials may be leading to a waste of
Externí odkaz:
https://doaj.org/article/2989d2842f46418db7c2868a877a3723
Publikováno v:
Engineering, Vol 6, Iss 10, Pp 1057-1060 (2020)
Externí odkaz:
https://doaj.org/article/35a3f5c85cc84aa79155202bc16c9039